Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
(Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that Nestor Jaramillo, Jr. retired as President and Chief Executive ...
Nuwellis CEO Nestor Jaramillo retires, John Erb named interim CEO
Nuwellis (NUWE) announced that Nestor Jaramillo retired as president and CEO and as a director of the company, effective February 18. John Erb, ...
Hosted on MSN21h
Nuwellis Appoints John Erb as Interim CEO
An announcement from Nuwellis ( ($NUWE) ) is now available. On February 24, 2025, Nuwellis, Inc. announced the retirement of Nestor Jaramillo, Jr.
Yahoo Finance3mon
Nuwellis, Inc. (NUWE)
Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page ...
Nasdaq5d
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow Ultrafiltration Therapy in Updated AVOID-HF Study Analysis
Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...
Hosted on MSN1mon
FDA issues “high-risk” safety alert to Nuwellis blood circuit sets
The US Food and Drug Administration (FDA) has issued an alert relating to a problem with blood circuit sets manufactured by Nuwellis that may be “high-risk”. Nuwellis sent affected customers ...
Benzinga.com4mon
Nuwellis (NASDAQ:NUWE) Stock Quotes, Forecast and News Summary
The FDA and Nuwellis warn of potential risks linked to AquaFlexFlow UF 500 Plus blood circuits. A recall addresses issues like therapy termination and patient injury risks.
Nasdaq6d
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
MINNEAPOLIS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today ...
CNN3y
Nuwellis, Inc.
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which ...
Nuwellis, Inc.: JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% reductio ...
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% ...